Chronic hepatitis C treated with peginterferon alfa plus ribavirin in clinical practice

BACKGROUND/AIMS: The role of genotype and viremia were retrospectively evaluated on sustained virological response (SVR) rates in routine clinical practice. METHODOLOGY: From 1907 patients with chronic hepatitis C proposed for treatment, we analysed 1380 (1124 naive and 256 treatment-experienced) wi...

ver descrição completa

Detalhes bibliográficos
Autor principal: Velosa, J (author)
Outros Autores: Serejo, F (author), Bana, T (author), Redondo, I (author), Simão, A (author), Vale, A (author), Pires, S (author), Macedo, G (author), Marinho, R (author), Peixe, P (author), Sarmento, J (author), Matos, L (author), Calinas, F (author), Carvalho, A (author), Figueiredo, A (author)
Formato: article
Idioma:eng
Publicado em: 2013
Assuntos:
Chronic hepatitis C
Interferon-alpha
Ribavirin
Hepatite C
Texto completo:http://hdl.handle.net/10400.10/883
País:Portugal
Oai:oai:repositorio.hff.min-saude.pt:10400.10/883

Texto Completo

http://hdl.handle.net/10400.10/883

Registos relacionados